Pegasys Injection, Solution
Product Images NDC 82154-0451

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Pegasys (NDC 82154-0451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaand Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Pegasys 01)

An instructional diagram showing the location of the expiration date on a product carton. The image illustrates the end flap of a box, highlighting where the EXP DATE is printed for user reference.*

FDA Label Image

Figure B (Pegasys 02)

An illustration diagram of a syringe showing labeled parts including the glass barrel, plunger rod, stopper, and rubber cap. The image highlights the structural components of a syringe used for subcutaneous injection.*

FDA Label Image

Figure C (Pegasys 03)

Illustration showing the location of the expiration date on a vial, labeled 'EXP DATE,' with an arrow pointing to the vial cap area.*

FDA Label Image

Figure D (Pegasys 04)

An instructional diagram showing a needle shield and green needle cover attached to a syringe or injection device, likely illustrating parts relevant to proper handling for a subcutaneous injection.*

FDA Label Image

Figure E (Pegasys 05)

An instructional line drawing illustrating the removal of a rubber cap from a vial using two hands. The image shows a syringe held by one hand and the other hand pulling the rubber cap upward from the vial's top. This likely demonstrates preparation steps for an injection.*

FDA Label Image

Figure F (Pegasys 06)

An instructional illustration showing hands preparing a subcutaneous injection using a syringe and a vial or similar medication container, relevant to Pegasys (peginterferon alfa-2a) injection solution.*

FDA Label Image

Figure G (Pegasys 07)

An instructional diagram showing hands preparing a subcutaneous injection using a syringe and vial. The illustration includes directional dots indicating twisting or turning motion, likely demonstrating how to attach or detach the needle or cap from the syringe or vial.*

FDA Label Image

Figure H (Pegasys 08)

An instructional diagram showing the parts of a prefilled syringe for subcutaneous injection, including labeled components: plunger rod, stopper, glass barrel, hub, green needle cover, and needle shield, associated with Pegasys (peginterferon alfa-2a) injection solution.*

FDA Label Image

Figure I (Pegasys 09)

Instructional illustration showing preferred subcutaneous injection sites for Pegasys (peginterferon alfa-2a) injection. The image highlights dotted areas on the lower abdomen and the front and outer sides of the thighs as suitable injection locations.*

FDA Label Image

Figure J (Pegasys 10)

An instructional diagram showing a hand holding a syringe for subcutaneous injection with labeled parts including a green needle cover and needle shield. The image illustrates the process of removing or positioning the needle shield before administration.*

FDA Label Image

Figure K (Pegasys 11)

An instructional diagram showing a hand holding a vial and a syringe. The syringe is labeled with parts such as 'Plunger Rod' and 'Hub.' The image likely illustrates the steps for drawing medication from the vial into the syringe.*

FDA Label Image

Figure L (Pegasys 12)

An instructional illustration showing a pair of hands preparing to administer a subcutaneous injection using a syringe. The syringe is held between the fingers and thumb, with the needle cap being removed or attached, demonstrating the proper technique for injection preparation.*

FDA Label Image

Figure M (Pegasys 13)

An instructional illustration showing a syringe with a plunger and needle being attached or removed from a vial. The vial has graduated markings indicating volume, and the syringe appears to be prepared for subcutaneous injection administration.*

FDA Label Image

Figure N (Pegasys 14)

An instructional diagram showing syringe markings for precise measurement of doses. The syringe barrel is labeled with graduation marks at 90, 135, and 180 mcg to indicate dosage levels for injection.*

FDA Label Image

Figure O (Pegasys 15)

An instructional diagram showing a syringe with a needle and an enlarged detail of the needle tip. The image emphasizes the sharpness or structure of the needle tip, likely related to subcutaneous injection technique for Pegasys (peginterferon alfa-2a) injection, solution.*

FDA Label Image

Figure P (Pegasys 16)

Illustration showing a hand placed on the front thigh area, likely indicating the site for a subcutaneous injection, relevant to the administration of Pegasys (peginterferon alfa-2a) injection solution.*

FDA Label Image

Figure Q (Pegasys 17)

An instructional diagram showing subcutaneous injection technique for Pegasys (peginterferon alfa-2a) injection solution. It illustrates needle insertion angles between 45 and 90 degrees into the skin for proper administration.*

FDA Label Image

Figure R (Pegasys 18)

An instructional line drawing showing a hand holding a syringe with a needle attached, poised for subcutaneous injection. The image appears to depict the proper method of handling or preparing the injection syringe, consistent with use of a solution dosage form.*

FDA Label Image

Figure S (Pegasys 19)

An instructional line drawing showing a hand holding a syringe with a needle inserted into a vial or ampule, demonstrating how to prepare or withdraw medication for injection. The image highlights the subcutaneous injection technique relevant to Pegasys (peginterferon alfa-2a) injection solution.*

FDA Label Image

Figure A (Pegasys 20)

Packaging label image of Pegasys (peginterferon alfa-2a) injection, solution for subcutaneous use. The image shows a mostly blank carton with a clearly marked location for the expiration date at the bottom center of the package front. No additional text, strength, or manufacturer marks are visible on the carton surface in the image.*

FDA Label Image

Figure B (Pegasys 21)

An instructional illustration showing a vial with a rubber stopper and a cap beside it. An arrow points to the vial's label indicating the location of the expiration date. The vial represents an injection solution container typically used for subcutaneous administration.*

FDA Label Image

Figure C (Pegasys 22)

An instructional illustration showing a hand gripping the cap of a vial or injection device with the thumb and forefinger, preparing to twist or pull the cap upward as indicated by an upward-pointing arrow above the cap.*

FDA Label Image

Figure D (Pegasys 23)

An instructional line drawing demonstrating the technique of administering a subcutaneous injection in the upper arm, likely related to the Pegasys (peginterferon alfa-2a) injection, solution product. The image shows one hand holding the skin fold while the other hand inserts the needle at an angle.*

FDA Label Image

Figure E (Pegasys 24)

An instructional illustration showing hands preparing a syringe. One hand holds a vial or syringe barrel; the other hand is pulling back the plunger of the syringe, indicating drawing up or measuring medication. An arrow points left, suggesting direction or motion.*

FDA Label Image

Figure F (Pegasys 25)

An instructional illustration showing a hand holding a syringe with a needle attached. The syringe is positioned above a vial, and a large eye icon suggests visual inspection of the solution before administration.*

FDA Label Image

Figure G (Pegasys 26)

An illustration of a vial with a needle inserted into its rubber stopper, representing a step commonly associated with preparing an injection. No text or branding is visible.*

FDA Label Image

Figure H (Pegasys 27)

An instructional line drawing showing a pair of hands holding a syringe and inserting a needle cap, demonstrating a step in preparing a subcutaneous injection. The image visually guides proper handling technique for the Pegasys (peginterferon alfa-2a) injection solution.*

FDA Label Image

Figure I (Pegasys 28)

An anatomical illustration showing recommended injection sites for Pegasys (peginterferon alfa-2a) injection, solution. The image depicts front and back views of a human torso and upper legs, with marked areas on the abdomen and outer thighs indicating subcutaneous injection locations.*

FDA Label Image

Figure J (Pegasys 29)

An instructional illustration showing a hand holding a prefilled injection syringe with a needle cap being removed by the other hand. The image demonstrates proper preparation of a subcutaneous injection, likely corresponding to Pegasys (peginterferon alfa-2a) injection solution.*

FDA Label Image

Figure K (Pegasys 30)

An instructional diagram showing a vial connected to a syringe with a close-up of the syringe needle tip inside a circular inset, illustrating a step in preparing or drawing an injection from the vial.*

FDA Label Image

Figure L (Pegasys 31)

An instructional line drawing showing a hand administering a subcutaneous injection into the knee area. The image demonstrates the correct hand placement and angle for subcutaneous injection, relevant for injectable drugs like Pegasys (peginterferon alfa-2a).*

FDA Label Image

Figure M (Pegasys 32)

Instructional illustrations showing the proper angle of injection for a subcutaneous injection, depicted as 45 to 90 degrees. The images demonstrate hand positioning and needle insertion into the skin for administering Pegasys injection solution.*

FDA Label Image

Pegasys-33 (Pegasys 33)

Label for Pegasys 180 mcg/mL injection, solution for subcutaneous use. The label indicates it is a single-use sterile product manufactured for zr pharma& GmbH, Austria, and distributed by Summit SD, LLC, Lee's Summit, MO. Storage instructions specify refrigeration at 2° to 8°C. Includes barcode and lot/expiration placeholders.*

FDA Label Image

Pegasys-34 (Pegasys 34)

Packaging label for Pegasys (peginterferon alfa-2a) Injection, Solution, 180 mcg/0.5 mL. The label indicates it is for subcutaneous injection only, sterile, with a monthly convenience pack containing 4 single-use prefilled syringes and 4 needles (27 gauge, 1/2 inch). The labeler is pharmaand GmbH.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.